NP / PA
Sheffield, Amy
Sheffield, Amy was paid $133K by Medicaid between Jan 2021 and Oct 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 22% of everything it billed.
33Billing provider infoSHEFFIELD, AMY
EVANSTON, IL 60202
EVANSTON, IL 60202
33aNPI1598156705assigned 02/10/2015
33bProvider typeFamily Nurse Practitioner
28Total paid$133K
24GClaims3,592
24DCodes billed25
24AFirst – last monthJan 2021 – Oct 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#555 of 3,353
Median peer was paid$25K
This provider vs. median5.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 72 | $3K | |
| 2022 | 134 | $5K | |
| 2023 | 517 | $23K | |
| 2024incomplete | 2,869 | $102K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 551 | 465 | $29K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 12% | 629 | 603 | $15K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.1% | 246 | 213 | $12K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.6% | 161 | 126 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.6% | 200 | 153 | $10K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7.1% | 47 | 42 | $9K |
| 87634 | 6.1% | 160 | 126 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5.1% | 192 | 145 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.7% | 153 | 124 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.6% | 73 | 64 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.6% | 73 | 64 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 80 | 58 | $2K |
13 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 73 | $2K |
| 87563 | 1.5% | 52 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.4% | 36 | $2K |
| 94760 | 1.3% | 464 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 44 | $1K |
| 87511 | <1% | 29 | $1K | |
| 80074 | <1% | 24 | $860.76 | |
| 86696 | <1% | 23 | $424.63 | |
| 81025 | <1% | 76 | $398.56 | |
| 81002 | <1% | 146 | $369.76 | |
| 86695 | <1% | 23 | $297.14 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 18 | $133.20 |
| 86592 | <1% | 19 | $76.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.